Purple Biotech Ltd ADR
(PPBT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 1,000 | 1,000 | 100 | 0 | 0 |
| Gross Profit | 1,000 | 1,000 | 100 | N/A | N/A |
| Operating Expenses | 8,156 | 8,826 | 12,066 | 7,183 | 4,069 |
| Operating Income | -7,156 | -7,826 | -11,966 | -7,183 | -4,069 |
| Interest Expense | 181 | 576 | 26 | 61 | 227 |
| Other Income | 1,660 | 2,833 | -921 | -4,881 | 94 |
| Pre-tax Income | -5,677 | -5,569 | -12,913 | -12,125 | -4,202 |
| Income Tax | 216 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -5,893 | -5,569 | -12,913 | -12,125 | -4,202 |
| Minority Interests | -43 | -369 | -736 | N/A | N/A |
| Net Income | $-5,850 | $-5,200 | $-12,177 | $-12,125 | $-4,202 |
| EPS Basic Total Ops | -60.00 | -78.00 | -274.00 | -421.40 | -873.13 |
| EPS Basic Continuous Ops | -60.85 | -78.41 | -273.10 | -421.32 | -873.13 |
| EPS Diluted Total Ops | -60.00 | -78.00 | -274.00 | -421.40 | -873.13 |
| EPS Diluted Continuous Ops | -60.85 | -78.41 | -273.10 | -421.32 | -873.13 |
| EPS Diluted Before Non-Recurring Items | -60.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-6,978 | $-7,819 | $-11,962 | $-7,181 | $-4,068 |